Panel Discussion: Multiomics, Longitudinal Data & Precision Medicine in the CNS: How Can we Get the Most Out of the Tools at Our Disposal?
Time: 9:00 am
day: Conference Day One
Details:
- Harnessing proteomics to identify early signatures of risk factors for neurodegenerative and neuroinflammatory disease
- Redefining disease heterogeneity with discrete biomarker populations
- Building up a network of internal and external capabilities to get the most out of complex patient data, producing quantitative biological insights
